Insider Selling: CryoPort (NASDAQ:CYRX) Insider Sells $21,322.00 in Stock

CryoPort, Inc. (NASDAQ:CYRX) insider Edward Zecchini sold 1,400 shares of the firm’s stock in a transaction dated Wednesday, June 10th. The stock was sold at an average price of $15.23, for a total value of $21,322.00. Following the completion of the transaction, the insider owned 109,719 shares of the company’s stock, valued at approximately $1,671,020.37. The trade was a 1.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

CryoPort Price Performance

Shares of NASDAQ:CYRX opened at $14.62 on Monday. CryoPort, Inc. has a 52-week low of $6.16 and a 52-week high of $16.73. The stock has a market cap of $736.85 million, a price-to-earnings ratio of 10.83 and a beta of 1.90. The business has a 50-day moving average price of $12.42 and a 200-day moving average price of $10.34.

CryoPort (NASDAQ:CYRX) last announced its quarterly earnings data on Monday, May 4th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.03). CryoPort had a negative return on equity of 7.92% and a net margin of 41.57%.The firm had revenue of $47.80 million during the quarter, compared to analysts’ expectations of $44.86 million. As a group, equities analysts anticipate that CryoPort, Inc. will post -0.85 EPS for the current fiscal year.

Institutional Trading of CryoPort

Several hedge funds and other institutional investors have recently bought and sold shares of CYRX. Mak Capital One LLC acquired a new stake in CryoPort during the third quarter worth about $7,756,000. UBS Group AG grew its holdings in CryoPort by 112.7% during the third quarter. UBS Group AG now owns 1,331,521 shares of the company’s stock worth $12,623,000 after acquiring an additional 705,649 shares during the period. Millennium Management LLC grew its holdings in CryoPort by 23.8% during the fourth quarter. Millennium Management LLC now owns 3,244,802 shares of the company’s stock worth $31,150,000 after acquiring an additional 623,896 shares during the period. Jacobs Levy Equity Management Inc. grew its holdings in CryoPort by 283.1% in the third quarter. Jacobs Levy Equity Management Inc. now owns 524,288 shares of the company’s stock valued at $4,970,000 after purchasing an additional 387,440 shares during the period. Finally, First Eagle Investment Management LLC acquired a new stake in CryoPort in the fourth quarter valued at approximately $2,996,000. 92.90% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on CYRX. Craig Hallum raised their price objective on CryoPort from $15.00 to $20.00 and gave the stock a “buy” rating in a research note on Wednesday, June 3rd. Jefferies Financial Group set a $13.50 target price on CryoPort in a report on Monday, June 8th. Guggenheim raised their target price on CryoPort from $11.00 to $12.00 and gave the stock a “buy” rating in a report on Tuesday, May 5th. Weiss Ratings raised CryoPort from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, May 6th. Finally, Wall Street Zen raised CryoPort from a “sell” rating to a “hold” rating in a report on Monday, May 11th. Eight analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, CryoPort currently has a consensus rating of “Moderate Buy” and a consensus target price of $15.11.

About CryoPort

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.